< Back to previous page
Researcher
Ward Celus
- Disciplines:Morphological sciences, Oncology
Affiliations
- Laboratory of Tumor Inflammation and Angiogenesis (VIB-KU Leuven) (Division)
Member
From1 Dec 2015 → 21 Mar 2022
Projects
1 - 1 of 1
- Unraveling the role of the PP2A regulatory subunit B55alpha in tumor-infiltrating immune cellsFrom1 Jul 2016 → 11 Feb 2022Funding: FWO Strategic Basic Research Grant, Nonprofit institution or equivalents
Publications
1 - 3 of 3
- Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer(2022)
Authors: Ward Celus, Silvia Rivis, Ewout Landeloos, Yannick Van Herck, Abhishek Garg, Chris Marine, Mario di Matteo, Oliver Bechter, Max Mazzone
Pages: 126 - 141 - B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling A Complementary Approach To Disrupt Pathological Vessels?(2020)
Authors: Ward Celus, Elizabeth Jones, Max Mazzone
Pages: 707 - 723 - Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis(2017)
Authors: Ward Celus, Manuel Ehling, Max Mazzone
Pages: 2842 - 2854
Patents
1 - 5 of 5
- Cd8+ t-cells lacking plexins and their application in cancer treatment (Inventor)
- Cancer treatment by targeting plexins in the immune compartment (Inventor)
- Biomarker for anti-tumor therapy (Inventor)
- Cd8+ t-cells lacking plexins and their application in cancer treatment (Inventor)
- Cancer treatment by targeting plexins in the immune compartment (Inventor)